Analysis of rifapentine for preventive therapy in the Cornell mouse model of latent tuberculosis - Test2 - elhamkhani - TriplyDB

Analysis of rifapentine for preventive therapy in the Cornell mouse model of latent tuberculosis

Analysis of rifapentine for preventive therapy in the Cornell mouse model of latent tuberculosis

http://www.wikidata.org/entity/Q28343546

about

Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts Tuberculosis: latency and reactivation Current approaches to tuberculosis in the United States.Models of latent tuberculosis: their salient features, limitations, and development.New regimens to prevent tuberculosis in adults with HIV infection Short-course therapy with daily rifapentine in a murine model of latent tuberculosis infection.Current management options for latent tuberculosis: a review.Treatment of Latent Tuberculosis Infection and Its Clinical Efficacy.

P2860

Q24650581-8F63C59C-42D0-4745-AD8C-4AE68BCA4F31 Q28201426-19885570-16FC-4895-AED5-74D6757A10AF Q34279727-1F94A6DC-3679-43FC-B0CE-4E683CB5ACC8 Q35646203-D455C50C-860C-4A32-B2AF-25E12AB27B17 Q36125227-BE8D147F-1D85-421E-9663-0EB880BF9F19 Q37443290-41CAC770-C47C-4D05-B707-2E79ADACF13D Q38066198-1D6142F7-3225-4EB1-BEC8-849000410F32 Q49521299-8C47B91B-C4DD-4C6D-AD16-D2A2F98DEBEB

P2860

Analysis of rifapentine for preventive therapy in the Cornell mouse model of latent tuberculosis

http://www.wikidata.org/entity/Q28343546

description

1999 nî lūn-bûn

@nan

1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Analysis of rifapentine for pr ...... e model of latent tuberculosis

@ast

Analysis of rifapentine for pr ...... e model of latent tuberculosis

@en

Analysis of rifapentine for pr ...... e model of latent tuberculosis

@nl

type

label

Analysis of rifapentine for pr ...... e model of latent tuberculosis

@ast

Analysis of rifapentine for pr ...... e model of latent tuberculosis

@en

Analysis of rifapentine for pr ...... e model of latent tuberculosis

@nl

prefLabel

Analysis of rifapentine for pr ...... e model of latent tuberculosis

@ast

Analysis of rifapentine for pr ...... e model of latent tuberculosis

@en

Analysis of rifapentine for pr ...... e model of latent tuberculosis

@nl

P1433

Q28343546-55F6E9F4-9821-4F85-8087-267D8CDDC99F

P1476

Q28343546-FB1F4DD9-2B34-4DED-928F-EA3018E2BFD1

P2093

Q28343546-23D1B298-DE70-49F3-9D00-049F5EB8A352

Q28343546-5AD6B421-CD10-47C8-AAA5-B897307DAF47

Q28343546-5FC0C750-7FC2-4FCD-B369-03EB94DBAE23

P2860

Q28343546-0408FAC7-BF79-4988-87BB-804D80B5B019

Q28343546-1061C2F0-4A5A-41FD-A19C-6894DE5DF314

Q28343546-116F4F7B-AA82-4A40-8411-DE82050713E8

Q28343546-11CD6E0A-7679-4F17-B9FC-548777BA1D1F

Q28343546-323A0BFD-0286-4C38-9200-B9874428539F

Q28343546-5C4A8D6E-5D38-489B-B65F-D63400036BD1

Q28343546-73E5F85C-535D-405D-A460-D5509EA7F404

Q28343546-788BF9B1-FB6C-4F92-8C73-0D5A8C31C0A6

Q28343546-7F2C9CA2-2506-46C5-9257-7FE3B19ABDB4

Q28343546-AB5628E3-A2F9-42B0-9BAA-471835C0C9CA

P304

Q28343546-4ED2B5BD-0F92-4A04-A159-D976378A3ACC

P31

Q28343546-231D089D-8074-4428-B5CC-200F1E2C3DB6

P356

Q28343546-FDBBABB9-29C3-4564-8647-70D57C76D0B6

P407

Q28343546-58EF10DB-2A0A-4A16-B410-482205DCD4BF

P433

Q28343546-E521D6BC-DB23-41F2-A444-2D454279A469

P478

Q28343546-385C7211-4CF9-421A-8B0A-3900D3C3EB62

P577

Q28343546-6695A8E7-F542-4177-BE44-B2974C8BA04A

P698

Q28343546-0F3F909A-FB3C-4FF1-B634-A62A4B30CC1B

P921

Q28343546-DB1D9D01-A0A1-4B6E-A55D-8B9F95ADD15B

P932

Q28343546-B489EA03-942B-4830-9C3F-5D32FA008965

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Analysis of rifapentine for pr ...... e model of latent tuberculosis

@en

P2093

E Miyazaki

http://www.w3.org/2001/XMLSchema#string

R E Chaisson

http://www.w3.org/2001/XMLSchema#string

W R Bishai

http://www.w3.org/2001/XMLSchema#string

P2860

Bactericidal activity in vitro of various rifamycins against Mycobacterium avium and Mycobacterium tuberculosis

Moxifloxacin (BAY12-8039), a new 8-methoxyquinolone, is active in a mouse model of tuberculosis

Comparison of activities of rifapentine and rifampin against Mycobacterium tuberculosis residing in human macrophages

HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention.

Mechanisms of latency in Mycobacterium tuberculosis.

Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues

A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration.

Controlled chemoprophylaxis trials in tuberculosis. A general review.

Preventive chemotherapy of tuberculosis in Cornell model mice with combinations of rifampin, isoniazid, and pyrazinamide.

In vitro properties of rifapentine (MDL473) relevant to its use in intermittent chemotherapy of tuberculosis.

P304

2126-2130

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.43.9.2126

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P577

1999-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10471552

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

P932

89434

http://www.w3.org/2001/XMLSchema#string